The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
The Global Ascendency of OXA-48-Type Carbapenemases
Open accessAbstract
Surveillance studies have shown that OXA-48-like carbapenemases are the most common carbapenemases in Enterobacterales in certain regions of the world and are being introduced on a regular basis into regions of nonendemicity, where they are responsible for nosocomial outbreaks. OXA-48, OXA-181, OXA-232, OXA-204, OXA-162, and OXA-244, in that order, are the most common enzymes identified among the OXA-48-like carbapenemase group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of acquired antimicrobial resistance genes
Zankari, E., Hasman, H., Cosentino, S., Vestergaard, M., Rasmussen, S., Lund, O., Aarestrup, F. M., & Larsen, M. V. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks261 · Cited by 4,980
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database
Jia, B., Raphenya, A. R., Alcock, B., Waglechner, N., Guo, P., Tsang, K. K., Lago, B. A., Dave, B. M., Pereira, S., Sharma, A. N., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1004 · Cited by 2,661
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Identification of plasmids by PCR-based replicon typing
Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K. L., & Threlfall, E. J. (2005) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2005.03.018 · Cited by 2,319
Multiplex PCR for detection of acquired carbapenemase genes
Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.002 · Cited by 1,991
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes
Gupta, S. K., Padmanabhan, B. R., Diene, S. M., Lopez-Rojas, R., Kempf, M., Landraud, L., & Rolain, J.-M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01310-13 · Cited by 1,476
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,229
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Mathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Self-citationCarbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Self-citationEvans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Poirel, L., & Dortet, L. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120355 · Cited by 761
Beta-lactamase database (BLDB) – structure and function
Naas, T., Oueslati, S., Bonnin, R. A., Dabos, M. L., Zavala, A., Dortet, L., Retailleau, P., & Iorga, B. I. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1344235 · Cited by 701
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wu, W., Feng, Y., Tang, G., Qiao, F., McNally, A., & Zong, Z. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-18 · Cited by 700
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679
Grundmann, H., Glasner, C., Albiger, B., Aanensen, D. M., Tomlinson, C. T., Andrasević, A. T., Cantón, R., Carmeli, Y., Friedrich, A. W., Giske, C. G., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30257-2 · Cited by 662
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
van der Zwaluw, K., de Haan, A., Pluister, G. N., Bootsma, H. J., de Neeling, A. J., & Schouls, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123690 · Cited by 486
Identification and screening of carbapenemase-producing Enterobacteriaceae
Nordmann, P., Gniadkowski, M., Giske, C. G., Poirel, L., Woodford, N., & Miriagou, V. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03815.x · Cited by 408
Pierce, V. M., Simner, P. J., Lonsway, D. R., Roe-Carpenter, D. E., Johnson, J. K., Brasso, W. B., Bobenchik, A. M., Lockett, Z. C., Charnot-Katsikas, A., Ferraro, M. J., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00193-17 · Cited by 405
Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases
Doyle, D., Peirano, G., Lascols, C., Lloyd, T., Church, D. L., & Pitout, J. D. D. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-12 · Cited by 363
Self-citationCastanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Rapid detection of carbapenemase genes by multiplex real-time PCR
Monteiro, J., Widen, R. H., Pignatari, A. C. C., Kubasek, C., & Silbert, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr563 · Cited by 358
Poirel, L., Decousser, J.-W., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2938-2945.2003 · Cited by 357
Proliferation and significance of clinically relevant β‐lactamases
Bush, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12023 · Cited by 337
Burckhardt, I., & Zimmermann, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00287-11 · Cited by 335
β-Lactamases: A Focus on Current Challenges
Bonomo, R. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025239 · Cited by 318
Potron, A., Poirel, L., Rondinaud, E., & Nordmann, P. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.31.20549 · Cited by 289
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Livermore, D. M., Mushtaq, S., Warner, M., Zhang, J., Maharjan, S., Doumith, M., & Woodford, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-10 · Cited by 261
Johnson, T. J., Bielak, E. M., Fortini, D., Hansen, L. H., Hasman, H., Debroy, C., Nolan, L. K., & Carattoli, A. (2012) · Plasmid · doi:10.1016/j.plasmid.2012.03.001 · Cited by 260
Carbapenemase-Producing Enterobacteriaceae
Paterson, D., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Hrabák, J., Chudáčkova, E., & Papagiannitsis, C. C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12678 · Cited by 233
Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France
Cuzon, G., Ouanich, J., Gondret, R., Naas, T., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01452-10 · Cited by 209
Metallo‐β‐Lactamases: A Class Apart
Bush, K. (1998) · Clinical Infectious Diseases · doi:10.1086/514922 · Cited by 205
OXA-48-like carbapenemases producing Enterobacteriaceae in different niches
Mairi, A., Pantel, A., Sotto, A., Lavigne, J.-P., & Touati, A. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3112-7 · Cited by 205
Harmer, C. J., & Hall, R. M. (2015) · Plasmid · doi:10.1016/j.plasmid.2015.04.003 · Cited by 180
Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs
Stolle, I., Prenger-Berninghoff, E., Stamm, I., Scheufen, S., Hassdenteufel, E., Guenther, S., Bethe, A., Pfeifer, Y., & Ewers, C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt259 · Cited by 180
Docquier, J.-D., Calderone, V., De Luca, F., Benvenuti, M., Giuliani, F., Bellucci, L., Tafi, A., Nordmann, P., Botta, M., Rossolini, G. M., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.04.010 · Cited by 176
Seale, A. C., Gordon, N. C., Islam, J., Peacock, S. J., & Scott, J. A. G. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12527.1 · Cited by 175
Carattoli, A., Seiffert, S. N., Schwendener, S., Perreten, V., & Endimiani, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123063 · Cited by 173
Valenza, G., Nickel, S., Pfeifer, Y., Eller, C., Krupa, E., Lehner-Reindl, V., & Höller, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01993-13 · Cited by 170
Characterization of OXA-181, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
Potron, A., Nordmann, P., Lafeuille, E., Al Maskari, Z., Al Rashdi, F., & Poirel, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00481-11 · Cited by 170
Characterization of OXA-204, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
Potron, A., Nordmann, P., & Poirel, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01034-12 · Cited by 169
Gülmez, D., Woodford, N., Palepou, M.-F. I., Mushtaq, S., Metan, G., Yakupogullari, Y., Kocagoz, S., Uzun, O., Hascelik, G., & Livermore, D. M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.017 · Cited by 168
Potron, A., Rondinaud, E., Poirel, L., Belmonte, O., Boyer, S., Camiade, S., & Nordmann, P. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.11.007 · Cited by 167
Ledeboer, N. A., Lopansri, B. K., Dhiman, N., Cavagnolo, R., Carroll, K. C., Granato, P., Thomson, R., Butler-Wu, S. M., Berger, H., Samuel, L., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00581-15 · Cited by 164
de Jonge, B. L. M., Karlowsky, J. A., Kazmierczak, K. M., Biedenbach, D. J., Sahm, D. F., & Nichols, W. W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03042-15 · Cited by 162
Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008–2014
Peirano, G., Matsumura, Y., Adams, M. D., Bradford, P., Motyl, M., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2406.171648 · Cited by 159
Self-citationMushi, M. F., Mshana, S. E., Imirzalioglu, C., & Bwanga, F. (2014) · BioMed Research International · doi:10.1155/2014/303104 · Cited by 158
Hedges, R. W., Datta, N., Kontomichalou, P., & Smith, J. T. (1974) · Journal of Bacteriology · doi:10.1128/jb.117.1.56-62.1974 · Cited by 158
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
Zowawi, H. M., Forde, B. M., Alfaresi, M. S., Alzarouni, A., Farahat, Y., Chong, T. M., Yin, W., Chan, K., Li, J., Schembri, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep15082 · Cited by 158
Poirel, L., Castanheira, M., Carrër, A., Rodriguez, C. P., Jones, R. N., Smayevsky, J., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-11 · Cited by 155
Potron, A., Poirel, L., & Nordmann, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01344-13 · Cited by 151
Oteo, J., Hernandez, J. M., Espasa, M., Fleites, A., Saéz, D., Bautista, V., Pérez-Vázquez, M. D., Fernández-García, M. D., Delgado‐Iribarren, A., Sánchez‐Romero, I., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks383 · Cited by 151
Poirel, L., Ros, A., Carricajo, A., Berthelot, P., Pozzetto, B., Bernabeu, S., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01305-10 · Cited by 148
Marchaim, D., Gottesman, T., Schwartz, O., Korem, M., Maor, ., Rahav, G., Karplus, R., Lazarovitch, T., Braun, E., Sprecher, H., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00565-10 · Cited by 145
Findlay, J., Hopkins, K. L., Meunier, D., & Woodford, N. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku571 · Cited by 135
Zurfluh, K., Poirel, L., Nordmann, P., Klumpp, J., & Stephan, R. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0080-5 · Cited by 112
van der Zee, A., Roorda, L., Bosman, G., Fluit, A. C., Hermans, M. H. A., Smits, P. H. M., van der Zanden, A. G., Witt, R. T., van Coppenraet, L. E. S. B., Stuart, J. W. T. C., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-27 · Cited by 112
Klebsiella pneumoniae ST307 with bla OXA-181, South Africa, 2014–2016
Lowe, M., Kock, M. M., Coetzee, J., Hoosien, E., Peirano, G., Strydom, K., Ehlers, M. M., Mbelle, N. M., Shashkina, E., Haslam, D. B., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181482 · Cited by 108
Self-citationWoodford, N., Eastaway, A., Ford, M., Leanord, A., Keane, C., Quayle, R. M., Steer, J. A., Zhang, J., & Livermore, D. M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00341-10 · Cited by 107
Liu, Y., Feng, Y., Wu, W., Xie, Y., Wang, X., Zhang, X., Chen, X., & Zong, Z. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00442-15 · Cited by 105
Antunes, N., & Fisher, J. F. (2014) · Antibiotics · doi:10.3390/antibiotics3030398 · Cited by 98
In Vivo Horizontal Gene Transfer of the Carbapenemase OXA-48 During a Nosocomial Outbreak
Göttig, S., Gruber, T. M., Stecher, B., Wichelhaus, T. A., & Kempf, V. A. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ191 · Cited by 98
Sidjabat, H. E., Townell, N., Nimmo, G. R., George, N., Robson, J. M. B., Vohra, R., Davis, L., Heney, C., & Paterson, D. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04378-14 · Cited by 98
Fursova, N. K., Astashkin, E. I., Lev, A. I., Kartsev, N. N., Kuzina, E. S., Ershova, O. N., Alexandrova, I. A., Kurdyumova, N. V., Sazikina, S. Y., Валентинович, В. Н., et al. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0108-y · Cited by 96
Torres‐González, P., Cervera-Hernandez, M. E., Niembro-Ortega, M. D., Leal-Vega, F. J., Cruz‐Hervert, L. P., García‐García, L., Galindo‐Fraga, A., Martínez‐Gamboa, A., Bobadilla-del-Valle, M., Sifuentes‐Osornio, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139883 · Cited by 94
Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae
Bernabeu, S., Poirel, L., & Nordmann, P. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.021 · Cited by 94
Espedido, B. A., Steen, J. A., Ziochos, H., Grimmond, S. M., Cooper, M. A., Gosbell, I. B., van Hal, S. J., & Jensen, S. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059920 · Cited by 90
Dautzenberg, M. J. D., Ossewaarde, J. M., de Kraker, M. E. A., van der Zee, A., van Burgh, S., de Greeff, S. C., Bijlmer, H. A., Grundmann, H., Stuart, J. W. C., Fluit, A. C., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20723 · Cited by 89
Strategy for Rapid Detection of Carbapenemase-Producing Enterobacteriaceae
Dortet, L., Bréchard, L., Cuzon, G., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01239-13 · Cited by 87
Hopkins, K. L., Meunier, D., Naas, T., Volland, H., & Woodford, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky342 · Cited by 87
Guo, L., An, J., Ma, Y., Ye, L., Luo, Y., Tao, C., & Yang, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160754 · Cited by 86
Skálová, A., Chudějová, K., Rotova, V., Medvecký, M., Študentová, V., Chudáčková, E., Lávička, P., Bergerová, T., Jakubů, V., Žemličková, H., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01889-16 · Cited by 86
Lutgring, J. D., Zhu, W., de Man, T. J. B., Avillan, J. J., Anderson, K. F., Lonsway, D. R., Rowe, L. A., Batra, D. G., Rasheed, J. K., & Limbago, B. M. (2018) · Emerging infectious diseases · doi:10.3201/eid2404.171377 · Cited by 86
Giani, T., Conte, V., Pilato, V. D., Aschbacher, R., Weber, C., Larcher, C., & Rossolini, G. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-12 · Cited by 85
Dortet, L., Oueslati, S., Jeannot, K., Tandé, D., Naas, T., & Nordmann, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05058-14 · Cited by 85
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
Findlay, J., Hopkins, K. L., Loy, R., Doumith, M., Meunier, D., Hill, R., Pike, R., Mustafa, N., Livermore, D. M., & Woodford, N. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx012 · Cited by 85
Cuzon, G., Naas, T., Bogaerts, P., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-08 · Cited by 83
Maurer, F. P., Castelberg, C., Quiblier, C., Bloemberg, G. V., & Hombach, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01692-14 · Cited by 83
Shu, L., Dong, N., Lu, J., Zheng, Z., Hu, J., Zeng, W., Sun, Q., Chan, E. W., Zhou, H., Hu, F., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02246-18 · Cited by 82
NDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas
Rojas, L. J., Hujer, A. M., Rudin, S. D., Wright, M. S., Domitrovic, T., Marshall, S. H., Hujer, K. M., Richter, S. S., Cober, E., Pérez, F., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00454-17 · Cited by 80
Samuelsen, Ø., Overballe‐Petersen, S., Bjørnholt, J. V., Brisse, S., Doumith, M., Woodford, N., Hopkins, K. L., Aasnæs, B., Haldorsen, B. C., Sundsfjord, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187832 · Cited by 74
OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories
Hoyos-Mallecot, Y., Naas, T., Bonnin, R. A., Patiño‐Navarrete, R., Glaser, P., Fortineau, N., & Dortet, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00818-17 · Cited by 72
Sonnevend, Á., Ghazawi, A., Hashmey, R., Haidermota, A., Girgis, S., Alfaresi, M. S., Omar, M., Paterson, D. L., Zowawi, H. M., & Pál, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00418-17 · Cited by 70
Complete Nucleotide Sequence of Plasmid Rts1: Implications for Evolution of Large Plasmid Genomes
Murata, T., Ohnishi, M., Ara, T., Kaneko, J., Han, C.-G., Li, Y. F., Takashima, K., Nojima, H., Nakayama, K., Kaji, A., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.12.3194-3202.2002 · Cited by 65
Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France
Poirel, L., Ros, A., Carrër, A., Fortineau, N., Carricajo, A., Berthelot, P., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr023 · Cited by 65
van Hattem, J. M., Arcilla, M. S., Bootsma, M., van Genderen, P. J. J., Goorhuis, A., Grobusch, M. P., Molhoek, N., Lashof, A. M. L. O., Schultsz, C., Stobberingh, E. E., et al. (2016) · Future Microbiology · doi:10.2217/fmb.16.18 · Cited by 65
Kieffer, N., Nordmann, P., Aires-de-Sousa, M., & Poirel, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01201-16 · Cited by 63
Travel-Related Carbapenemase-Producing Gram-Negative Bacteria in Alberta, Canada: the First 3 Years
Peirano, G., Ahmed-Bentley, J., Fuller, J., Rubin, J. E., & Pitout, J. D. D. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00162-14 · Cited by 61
Self-citationEmergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan
Ma, L., Wang, J., Wu, T., Siu, L.-K. K., Chuang, Y.-C., Lin, J., Lu, M., & Lu, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139152 · Cited by 61
Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates
Yin, D., Dong, D., Li, K., Zhang, L., Liang, J., Yang, Y., Wu, N., Bao, Y., Wang, C., & Hu, F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00385-17 · Cited by 61
First description of blaNDM-1, blaOXA-48, blaOXA-181 producing Enterobacteriaceae strains in Romania
Székely, E., Damjanova, I., Jánvári, L., Vas, K., Molnár, S., Bilca, D., Lőrinczi, L. K., & Tóth, Á. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.10.001 · Cited by 59
Villa, L., Carattoli, A., Nordmann, P., Carta, C., & Poirel, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01297-12 · Cited by 59
Avgoulea, K., Pilato, V. D., Zarkotou, O., Sennati, S., Politi, L., Cannatelli, A., Themeli-Digalaki, K., Giani, T., Tsakris, A., Rossolini, G. M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02457-17 · Cited by 59
Laolerd, W., Akeda, Y., Preeyanon, L., Ratthawongjirakul, P., & Santanirand, P. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0080 · Cited by 59
Seiffert, S. N., Perreten, V., Johannes, S., Droz, S., Bodmer, T., & Endimiani, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02417-13 · Cited by 57
Improved assay-dependent searching of nucleic acid sequence databases
Gans, J. D., & Wolinsky, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn301 · Cited by 57
Low, Y. M., Yap, P. S. X., Jabar, K. A., Ponnampalavanar, S. S. L., Karunakaran, R., Velayuthan, R. D., Chong, C. W., AbuBakar, S., Yusof, M. Y. M., & Teh, C. S. J. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-016-0164-x · Cited by 55
Gharbi, M., Moore, L. S. P., Gilchrist, M. J., Thomas, C. P., Bamford, K. B., Brannigan, E., & Holmes, A. H. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.005 · Cited by 54
Lau, A. F., Fahle, G. A., Kemp, M. A., Jassem, A. N., Dekker, J. P., & Frank, K. M. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01921-15 · Cited by 53
Hall, J. M., Corea, E. M., Sanjeewani, H. D. A., & Inglis, T. J. J. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.076760-0 · Cited by 52
Mathers, A. J., Carroll, J., Sifri, C. D., & Hazen, K. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03240-12 · Cited by 50
Genomics of Klebsiella pneumoniae ST16 producing NDM-1, CTX-M-15, and OXA-232
Espinal, P., Nucleo, E., Caltagirone, M., Marchetti, V. M., Fernandes, M. R., Biscaro, V., Rigoli, R., Carattoli, A., Migliavacca, R., & Villa, L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.004 · Cited by 50
Chen, L., Laham, N. A., Chavda, K. D., Mediavilla, J. R., Jacobs, M. R., Bonomo, R. A., & Kreiswirth, B. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00565-15 · Cited by 49
Kabir, M. H., Meunier, D., Hopkins, K. L., Giske, C. G., & Woodford, N. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv468 · Cited by 49
Sangare, S. A., Rondinaud, E., Maataoui, N., Maïga, A. I., Guindo, I., Maïga, A., Camara, N., Dicko, O. A., Dao, S., Diallo, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172652 · Cited by 49
Ghany, M. A. E., Sharaf, H., Al-Agamy, M. H., Shibl, A. M., Hill-Cawthorne, G. A., & Hong, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201613 · Cited by 49
Srisrattakarn, A., Lulitanond, A., Wilailuckana, C., Charoensri, N., Wonglakorn, L., Saenjamla, P., Chaimanee, P., Daduang, J., & Chanawong, A. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2295-5 · Cited by 48
Jeong, S. H., Kim, H.-S., Kim, J., Shin, D. H., Kim, H. S., Park, M.-J., Shin, S., Hong, J. S., Lee, S. S., & Song, W. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2016.36.6.529 · Cited by 47
Yang, S., Hemarajata, P., Hindler, J. A., Li, F., Adisetiyo, H., Aldrovandi, G. M., Sebra, R., Kasarskis, A., MacCannell, D., Didelot, X., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw876 · Cited by 47
Aung, M. S., San, N., Maw, W. W., San, T., Urushibara, N., Kawaguchiya, M., Sumi, A., & Kobayashi, N. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0387 · Cited by 47
McGann, P., Snesrud, E. C., Ong, A., Appalla, L., Koren, M. A., Kwak, Y. I., Waterman, P. E., & Lesho, E. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04442-14 · Cited by 46
Begum, N., & Shamsuzzaman, S. (2016) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2016.04.005 · Cited by 46
Emergence of an MDR Klebsiella pneumoniae ST231 producing OXA-232 and RmtF in Switzerland
Mancini, S., Poirel, L., Tritten, M.-L., Lienhard, R., Bassi, C., & Nordmann, P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx428 · Cited by 46
Co-Production of NDM-1 and OXA-232 by ST16 Klebsiella Pneumoniae , Italy, 2016
Avolio, M., Vignaroli, C., Crapis, M., & Camporese, A. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0041 · Cited by 45
Adler, A., Solter, E., Masarwa, S., Miller-Roll, T., Abu‐Libdeh, B., Khammash, H., Najem, K., Dekadek, S., Stein‐Zamir, C., Nubani, N. H., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01049-13 · Cited by 44
Lunha, K., Chanawong, A., Lulitanond, A., Wilailuckana, C., Charoensri, N., Wonglakorn, L., Saenjamla, P., Chaimanee, P., Angkititrakul, S., & Chetchotisakd, P. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.03.009 · Cited by 44
Zautner, A. E., Bunk, B., Pfeifer, Y., Spröer, C., Reichard, U., Eiffert, H., Scheithauer, S., Groß, U., Overmann, J., & Bohne, W. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx216 · Cited by 42
Environmental persistence of OXA-48–producing Klebsiella pneumoniae in a French intensive care unit
Pantel, A., Richaud-Morel, B., Cazaban, M., Bouziges, N., Sotto, A., & Lavigne, J. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.09.021 · Cited by 40
Nahid, F., Zahra, R., & Sandegren, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189438 · Cited by 40
Concurrent interspecies and clonal dissemination of OXA-48 carbapenemase
Arana, D. M., Saéz, D., García-Hierro, P., Bautista, V., Fernández-Romero, S., de la Cal, M. A., Alós, J.-I., & Oteo, J. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.008 · Cited by 39
Momin, M. H. F. A., Liakopoulos, A., Phee, L. M., & Wareham, D. W. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.02.008 · Cited by 38
Jacobson, R. K., Manesen, M. R., Moodley, C., Smith, M., Williams, S., Nicol, M. P., & Bamford, C. (2015) · South African Medical Journal · doi:10.7196/samj.2015.v105i12.9926 · Cited by 37
Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae
Matsumura, Y., & Pitout, J. D. D. (2016) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1172964 · Cited by 36
Self-citationEpidemic spread of OXA-48 beta-lactamase in Croatia
Bedenić, B., Slade-Vitković, M., Žele-Starčević, L., Sardelić, S., Vranić-Lađavac, M., Benčić, A., Atalić, V. Z., Bogdan, M., Bubonja‐Šonje, M., Tomić-Paradžik, M., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000777 · Cited by 36
Characterization of OXA-48-like carbapenemase producers in Canada, 2011–14
Mataseje, L. F., Boyd, D. A., Fuller, J., Haldane, D. J. M., Hoang, L., Lefebvre, B., Melano, R. G., Poutanen, S. M., Caeseele, P. G. V., & Mulvey, M. R. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx462 · Cited by 35
Mierzejewska, J., Kulińska, A., & Jagura‐Burdzy, G. (2006) · Plasmid · doi:10.1016/j.plasmid.2006.09.001 · Cited by 34
Samuelsen, Ø., Naseer, U., Karah, N., Lindemann, P. C., Kanestrøm, A., Leegaard, T. M., & Sundsfjord, A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt058 · Cited by 34
Pérez-Vázquez, M. D., Oteo, J., García-Cobos, S., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv458 · Cited by 34
Cunningham, S. A., Vasoo, S. S., & Patel, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03302-15 · Cited by 34
Emergence of Escherichia coli producing OXA-48 β-lactamase in the community in Switzerland
Zurfluh, K., Nüesch‐Inderbinen, M., Poirel, L., Nordmann, P., Hächler, H., & Stephan, R. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0051-x · Cited by 33
Samuelsen, Ø., Hansen, F., Aasnæs, B., Hasman, H., Lund, B. A., Leiros, H. S., Lilje, B., Janice, J., Jakobsen, L., Littauer, P., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01260-17 · Cited by 33
Poirel, L., Aires-de-Sousa, M., Kudyba, P., Kieffer, N., & Nordmann, P. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01021-18 · Cited by 33
Hemarajata, P., Yang, S., Hindler, J. A., & Humphries, R. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-15 · Cited by 31
Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand
Williamson, D. A., Heffernan, H., Sidjabat, H. E., Roberts, S. A., Paterson, D. L., Smith, M., & Freeman, J. T. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr396 · Cited by 30
Imipenem-Susceptible, Meropenem-Resistant Klebsiella pneumoniae Producing OXA-181 in Japan
Kayama, S., Koba, Y., Shigemoto, N., Kuwahara, R., Kakuhama, T., Kimura, K., Hisatsune, J., Onodera, M., Yokozaki, M., Ohge, H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04330-14 · Cited by 28
Grami, R., Mansour, W., Khalifa, A. B. H., Dahmen, S., Châtre, P., Haenni, M., Aouni, M., & Madec, J.-Y. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0278 · Cited by 27
Lund, B. A., Thomassen, A. M., Carlsen, T. J. O., & Leiros, H. S. (2017) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x17013838 · Cited by 27
Potron, A., Bernabeu, S., Cuzon, G., Pontiès, V., Blanchard, H., Seringe, E., Naas, T., Nordmann, P., & Dortet, L. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.49.17-00048 · Cited by 27
Use of Faropenem as an Indicator of Carbapenemase Activity in the Enterobacteriaceae
Day, K. M., Pike, R., Winstanley, T. G., Lanyon, C. V., Cummings, S. P., Raza, M. W., Woodford, N., & Perry, J. D. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00720-13 · Cited by 26
Piazza, A., Comandatore, F., Romeri, F., Pagani, C., Floriano, A. M., Ridolfo, A., Antona, C., Brilli, M., Marchetti, V. M., Bandi, C., et al. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0366 · Cited by 26
blaOXA-181–positiveKlebsiella pneumoniae, Singapore
Koh, T. H., Cao, D. Y. H., Chan, K. S., Wijaya, L., Low, S. B. G., Lam, M. S., Ooi, E. E., & Hsu, L. Y. (2012) · Emerging infectious diseases · doi:10.3201/eid1809.111727 · Cited by 25
Novais, Â., Brilhante, M., Pires, J., & Peixe, L. M. S. V. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01170-15 · Cited by 24
Ouédraogo, A.-S., Compain, F., Sanou, M., Aberkane, S., Bouzinbi, N., Hide, M., Sangaré, L., Ouédraogo-Traoré, R., Jean-Pierre, H., Vendrell, J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00147-16 · Cited by 23
Fernández, S. G., Morosini, M.-I., Gijón, D., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02580-15 · Cited by 22
Zhao, Y., Wang, L., Zhang, Z., Feng, J., Kang, H., Fang, L., Jiang, X., Zhang, D., Zhan, Z., Zhou, D., et al. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0067 · Cited by 22
Early emergence of OXA-181-producing Escherichia coli ST410 in China
Qin, S., Cheng, J., Wang, P., Feng, X., & Liu, H. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.06.017 · Cited by 22
Emergence of OXA-204 β-lactamase in Tunisia
Charfi, K., Mansour, W., Khalifa, A. B. H., Mastouri, M., Aouni, M., & Mammeri, H. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.04.003 · Cited by 21
Ceyssens, P., García-Graells, C., Fux, F., Botteldoorn, N., Mattheus, W., Wuyts, V., Keersmaecker, S. C. J. D., Dierick, K., & Bertrand, S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw201 · Cited by 21
Oueslati, S., Girlich, D., Dortet, L., & Naas, T. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01092-17 · Cited by 21
Stoesser, N. E., Sheppard, A. E., Peirano, G., Sebra, R., Lynch, T., Anson, L. W., Kasarskis, A., Motyl, M. R., Crook, D. W., & Pitout, J. D. D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01130-16 · Cited by 20
Self-citationOhsaki, Y., Kubo, R., Hobson, J., et al. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12553 · Cited by 18
Dautzenberg, M. J. D., Ossewaarde, J. M., de Greeff, S. C., Troelstra, A., & Bonten, M. J. M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw119 · Cited by 16
Emergence of OXA-162-producing Klebsiella pneumoniae in Hungary
Jánvári, L., Damjanova, I., Lázár, A., Rácz, K., Kocsis, B., Urbán, E. Z., & Tóth, Á. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2013.879993 · Cited by 14
Ho, P., Wang, Y., Tse, C. W., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01110-17 · Cited by 14
Woerther, P., Jardak, T., Hassine, I. B., Forget, S., Chachaty, É., Arlet, G., & Decré, D. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0060 · Cited by 7
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147
Peirano, G., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01148-20 · Cited by 363
Self-citationMa, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127249 · Cited by 308
Hammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Bahr, G., González, L. J., & Vila, A. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00138 · Cited by 266
Metadata
- Authors
- Pitout, J. D. D., Peirano, G., Kock, M. M., Strydom, K.-A., & Matsumura, Y.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2019-12-18
- Volume
- 33
- Issue
- 1
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2987720685
- Cited by
- 478
- References
- 166
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.